Related Experiment Video

Updated: Aug 19, 2025

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

10.8K

PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor

Sonia Missiroli1, Mariasole Perrone1, Roberta Gafà2

  • 1Department of Medical Sciences, Section of Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.

Cell Death and Differentiation
|November 30, 2022
PubMed

Insights

The tumor suppressor PML normally restrains immune responses in the tumor microenvironment (TME). Loss of PML causes uncontrolled inflammation, boosting cancer growth and worsening patient prognosis.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • The tumor microenvironment (TME) drives cancer progression through uncontrolled inflammation.
  • Identifying mechanisms that regulate TME inflammation is crucial for developing cancer therapies.

Purpose of the Study:

  • To investigate the role of the tumor suppressor PML in regulating the P2X7 receptor (P2X7R)-NLRP3 inflammasome axis within mitochondria-associated membranes (MAMs).
  • To elucidate how PML dysfunction impacts immune responses and cancer progression.

Main Methods:

  • Analysis of a trimeric complex involving PML, P2X7R, and NLRP3 at MAMs.
  • Investigation of PML's effect on P2X7R-NLRP3 regulation and cytokine release.
  • Evaluation of PML's role in various human cancers.

Main Results:

  • PML downregulation disrupts the P2X7R-NLRP3 complex at MAMs, leading to excessive immune activation.
  • PML mislocalization from MAMs results in uncontrolled NLRP3 inflammasome activation and a cytokine storm.
  • This uncontrolled inflammation fuels cancer progression and correlates with poor prognosis across multiple cancer types.

Conclusions:

  • The PML-P2X7R-NLRP3 axis is a key regulator of the TME in human carcinogenesis.
  • PML loss of function exacerbates inflammation, promoting tumor growth and worsening outcomes.
  • Targeting this axis offers potential therapeutic strategies for cancer treatment.

More Related Videos

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

21.0K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.6K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
630
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K